FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Lawyers Predict Gottlieb Imminent Confirmation

An Epstein Becker & Green client alert predicts an imminent confirmation of Scott Gottlieb to be the next FDA commissioner, which should be a win for ...

Medical Devices

FDA Clears Esophageal Cooling Device

FDA clears an Advanced Cooling Therapy 510(k) for use of its Esophageal Cooling Device with the Altrix Precision Temperature Management System by Stry...

Human Drugs

Courts Narrowing Liability Under False Claims Act

Two attorneys say a recent Pennsylvania federal court decision shows courts are narrowing the situations in which they impose liability under the Fals...

Medical Devices

FDA Clears Additive Orthopedics Plating System

FDA clears an Additive Orthopedics 510(k) for its 3D printed Locking Lattice Plating System and its use to address stabilization and fusion of fractur...

Medical Devices

FDA Clears Entellus ENT Dilation System

FDA clears an Entellus Medical 510(k) for the XprESS ENT Dilation System and its use in patients with persistent Eustachian tube dysfunction.

Human Drugs

Few Cancer Drugs to Work with Radiation: FDA Staff

CDER Office of Hematology and Cancer Products staff list possible reasons why only one drug has been approved since 2006 for use with radiation in cur...

Medical Devices

FBI Warns of FTP Cybersecurity Risk

Attorney Kate Stewart says the FBI is warning about the cybersecurity risk in FTP servers in healthcare facilities operated in an anonymous configurat...

Federal Register

Comment Period Extended on Animal DNA Guidance

Federal Register notice: FDA extends the comment period for the draft guidance for industry #187 Regulation of Intentionally Altered Genomic DNA in An...

Federal Register

FDA Exempts 71 Class 1 Devices from 510(k) Submissions

Federal Register notice: FDA identifies 71 Class 1 devices that are now exempt from premarket notification requirements.

Human Drugs

REMS No Longer Needed for Amgens Anemia Drugs: FDA

FDA determines that Amgens erythropoiesis-stimulating agents epoetin alfa (Procrit and Epogen) and darbepoetin alfa (Aranesp) no longer require a Risk...